Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug
In This Article:
The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.